Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo

Cancer Chemotherapy and Pharmacology

Volumn 42, Issue 1, 1998, Pages 24-30

  Teicher, Beverly A ^a,b   Wong, Julia S ^a   Takeuchi, Hideya ^a   Gravelin, Laura M ^a   Ara, Gulshan ^a   Buxton, David ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Allosteric effectors; Chemosensitzation; Combined modality therapy; Radiosensitization

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; ANTIMETASTATIC AGENT; BEZAFIBRATE; CARBOPLATIN; CLOFIBRATE; EFAPROXIRAL; HEMOGLOBIN; PROPIONIC ACID DERIVATIVE; THIOTEPA; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER TRANSPLANTATION; CELL CULTURE; CELL KILLING; CELL VIABILITY; CHEMOSENSITIVITY; COLONY FORMATION; CONTROLLED STUDY; HYPOXIA; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOSENSITIZATION; SURVIVAL RATE; TUMOR GROWTH;

ALLOSTERIC REGULATION; ANILINE COMPOUNDS; ANIMALS; ANTISICKLING AGENTS; BONE MARROW CELLS; CARCINOMA, LEWIS LUNG; COLONY-FORMING UNITS ASSAY; COMBINED MODALITY THERAPY; FEMALE; HEMOGLOBINS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; PROPIONIC ACIDS; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0031967675     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050780     Document Type: Article

References (39)

1. Abraham DJ, Perutz MF, Phillips SEV (1983) Physiological and x-ray studies of potential antisickling agents. Proc Nail Acad Sci USA 80: 324
2. Abraham DJ, Wireko FC, Randad RS (1992) Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry 31: 9141
3. Abraham DJ, Kister J, Joshi GS, Marden MC, Poyart C (1995) Intrinsic activity at the molecular level: E.J. Ariëns concept visualized. J Mol Biol 248: 845
4. Alberts A, Chen J, Kuron G, Hunt V, Hoffman C (1980) Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase and a cholestral lowering agent. Proc Natl Acad Sci USA 77: 3957
5. Andersson C, Jensen E, Llewellyn D, Dennis E, Peacock W (1996) A new hemoglobin gene from soybean: a role for hemoglobin in all plants. Proc Natl Acad Sci USA 93: 5682
6. Chen H, Shapiro D (1990) Nucleotide sequence and estrogen induction of Xenopus laevis 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 265: 4622
7. Friesen J, Lawrence C, Stauffacher C, Rodwell V (1996) Structural determinants of nucleotide coenzyme specificity in the distinctive dinucleotide binding fold of HMG-CoA reductase from Pseudomonas mevalonii. Biochemistry 35: 11945
8. Grundy M, Vega L (1987) Fibric acids: effects on lipids and lipoprotein metabolism. Am J Med 83: 9
9. Hall EJ (1978) Radiobiology for the radiobiologist. Harper & Row, Philadelphia, p 235
10. Hardison R (1996) A brief history of hemoglobine: animal, protist and bacteria. Proc Natl Acad Sci USA 93: 5675
11. Hayashi F, Tamura H, Watanabe T, Suga T (1995) Enhancement by peroxisome proliferators of the susceptibility to DNA damage in the liver of male F344 rats. Cancer Lett 92: 87
12. Hilgard P (1984) Anticoagulants and tumor growth: pharmacological considerations. In: Nicolson GL, Milas L (eds) Cancer invasion and metastasis: biologic and therapeutic aspects. Raven Press, New York, p 353
13. Hirst DG, Wood PJ, Schwartz HC (1987) The modification of tumor radiosensitivity by antilipidemic drugs. Radial Res 112: 164
14. Hoffman W, Alberts A, Anderson P, Chen J, Smith R, Willard A (1986) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors: 4 Side chain ester derivatives of mevinolin. J Med Chem 29: 849
15. Jani JP, Specht S, Stemmler N, Blanock K, Singh SV, Gupta V, Katoh A (1995) Metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis. Invasion Metastasis 13: 314
16. Khandelwal SR, Randad RS, Lin P-S, Meng H, Pittman RN, Kontos HA, Choi S, Abraham DJ, Schmidt-Ullrich R (1993) Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation. Am J Physiol 265: H1450
17. Learned R, Fink G (1989) 3-Hydroxy-3-methylglutaryl-coenzyme A reductase fro Arabidopsis thaliana is structurally distinct from the yeast and animal enzymes. Proc Natl Acad Sci USA 86: 2779
18. Pacot C, Petit M, Caira F, Rollin M, Behechti N, Grégoire S, Malki MC, Cavatz C, Moisant M, Moreau C, Thomas C, Descotes G, Gallas J-F, Deslex P, Althoff J, Zahnd J-P, Lhuguenot J-C, Latruffe N (1993) Response of genetically obese Zucker rats to ciprofibrate, a hypolipidemic agent, with peroxisome proliferation activity compared to Zucker lean and Sprague-Dawley rats. Biol Cell 77: 27
19. Perutz MF, Poyart C (1983) Bezafibrate lowers oxygen affinity of haemoglobin. Lancet 2: 881
20. Rockwell SC, Kallman RF, Fajardo LF (1972) Characteristics of serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J Natl Cancer Inst 49: 735
21. Rockwell S, Kallman RF (1973) Cellular radiosensitivity and tumor radiation response in the EMT-6 tumor cell system. Radiat Res 53: 281
22. Rockwell S (1977) In vivo-in vitro tumor systems: new models for studying the response of tumors to therapy. Lab Anim Sci 27: 831
23. Rockwell S (1978) Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT-6 mouse mammary tumor cells in vivo and in vitro. Br J Cancer 37: 212
24. Rubin P, Casarett G (1966) Microcirculation of tumors part I: anatomy, function and necrosis. Clin Radiol 17: 220
25. Sebolt-Leopold J (1997) A case for ras targeted agents as antineoplastics. In: Teicher B (ed) Cancer therapeutics: experimental and clinical agents. Humana Press, Totowa, p 395
26. Shipley WV, Stanley JA, Steel GG (1975) Tumor size dependence in the radiation response of the Lewis lung carcinoma. Cancer Res 35: 2488
27. Siemann DW, Macler LM (1986) Tumor radiosensitization through reductions in hemoclobin affinity, Int J Radiat Oncol Biol Phys 12: 1295
28. Sotomayor EA, Teicher BA, Schwartz GN, Holden SA, Menon K, Herman TS, Frei III E (1992) Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo. Cancer Chemother Pharmacol 30: 377
29. Stanley JA, Shipley WV, Steel GG (1977) Influence of tumor size of hypoxic fraction and therapeutic sensitivity of Lewis lung tumor. Br J Cancer 36: 105
30. Steel GG, Nill RP, Peckham MJ (1978) Combined radiotherapy-chemotherapy of Lewis lung carcinoma. Int J Radiat Oncol Biol Phys 4: 49
31. Tannock IF, Hill RP (1992) The basic science of oncology. McGraw-Hill, Toronto, p 285
32. Teicher BA, Holden SA, Jacobs JL (1987) Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity. Cancer Res 47: 513
33. Teicher BA, Holden SA, Eder JP, Herman TS, Antman KH, Frei E III (1990) Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination. Semin Oncol 17: 18
34. Teicher BA, Dupuis N, Kusumoto T, Robinson MF, Liu F, Menon K, Coleman CN (1995) Antiangiogenic agents can increase tumor oxygenation and response to radiation therapy. Radiat Oncol Invest 2: 269
35. Tsujita Y, Kuroda M, Shimada Y, Tanzawa K (1986) CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase selective inhibition of steroid synthesis and hypolipidemic effects on various animal species. Biochim Biophys Acta 877: 50
36. Vliet A van, Negre-Aminou P, Christa G, Bolhuis P, Cohen L (1996) Action of lovastatin. simvastatin and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle. Biochem Pharm 32: 1387
37. 2 saturation of hemoglobin on cerebral vasodilation from hypoxia and hypotension. Am J Physiol 265: H1439
38. Wilkin D, Kutsunai S, Edwards P (1990) Isolation and sequence of the human farnesyl pyrophosphate synthetase cDNA. J Biol Chem 265: 4607
39. Wooton R (1984) Analysis of the effect of bezafibrate on the oxygen dissociation curve of human hemoglobin. FEBS Lett 171: 187